Aurora cannabis announces fiscal 2026 first quarter results

Nasdaq | tsx: acb expands yoy global medical cannabis net revenue 1 by 37% to $64.8 million, while increasing international medical cannabis net revenue 1 by 85% to $37.1 million delivers adjusted ebitda 1  growth in excess of 200%, reaching $10.8 million generates positive free cash flow 1 of $9.2 million, representing significant yoy growth of 42% maintains strong balance sheet with ~$186.0 million of cash and debt-free cannabis business 2 edmonton, ab , aug. 6, 2025 /prnewswire/ - aurora cannabis inc. (the "company" or "aurora") (nasdaq: acb) (tsx: acb), a leading canada-based global medical cannabis company, today announced its financial and operational results for the first quarter 2026 period ending june 30, 2025. "we delivered another strong quarter of sustained, profitable growth, driven by disciplined execution of our strategy.
ACB Ratings Summary
ACB Quant Ranking